Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation (Nature Communications, 2021)

(untitled) - Ryzhakov, G; Almuttaqi, H; Corbin, A; Berthold, DL; Khoyratty, T; Eames, H; Bullers, S; Pearson, C; Ai, Z; Zec, K; Bonham, S; Fischer, R; et al.